Proposed Addition to Appendix D of the NIH Guidelines Regarding a Human 
Gene Transfer Protocol Entitled Autologous Transplantation for Chronic 
Myelogenous Leukemia: Retroviral Marking to Discriminate Between Relapses 
Arising from Residual System Disease Versus Residual Contamination of 
Autologous Marrow 
Dr. Deisseroth 
Proposed Additions to Appendix D of the NIH Guidelines Regarding Human 
Gene Transfer Protocols Entitled A Phase //// Trial of High-Dose 
Carboplatin and Etoposide with Autologous Marrow Support for Treatment 
of Stage D Neuroblastoma in First Remission: Use of Marker Genes to 
Investigate the Biology of Marrow Reconstitution and the Mechanism of 
Relapse; and a Phase II Trial of High-Dose Carboplatin and Etoposide 
with Autologous Marrow Support for Treatment of Relapse/Refractory 
Neuroblastoma Without Apparent Bone Marrow Involvement: Use of Marker 
Genes to Investigate the Biology of Marrow Reconstitution and the 
Mechansim of Relapse 
Dr. Brenner 
Proposed Amendment to Section I-C-2 and Deletion of Section III-A-2 of 
the NIH Guidelines Regarding Deliberate Release 
Dr. Hirano 
Background Information on the Registry of Gene Transfer Patients Entitled 
The Gene Transfer Patient and Provider Network (Genetranet) 
Dr. Ledley 
Future Meeting Dates of the Recombinant DNA Advisory Committee and the 
Human Gene Therapy Subcommittee 
Dr. McGarrity 
Adjournment 
Dr. McGarrity 
[606] 
Recombinant DNA Research, Volume 14 
